Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
15.00
-0.29 (-1.90%)
Oct 16, 2025, 4:00 PM EDT - Market closed

COEP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
721127302,494338
Upgrade
Market Cap Growth
911.91%-57.71%-10.53%-98.80%637.84%-
Upgrade
Enterprise Value
711226262,497338
Upgrade
Last Close Price
15.005.5015.6830.63200.00203.80
Upgrade
PS Ratio
154.05---33258.2310990.00
Upgrade
PB Ratio
10.252.9232.856.711061.15-65.73
Upgrade
P/TBV Ratio
15.754.2832.856.711061.15-
Upgrade
EV/Sales Ratio
268.07---33296.4410981.90
Upgrade
Debt / Equity Ratio
0.190.361.500.461.74-0.41
Upgrade
Asset Turnover
0.03---0.020.03
Upgrade
Quick Ratio
0.670.120.511.750.790.04
Upgrade
Current Ratio
0.830.230.591.810.790.04
Upgrade
Return on Equity (ROE)
-372.12%-464.73%-807.49%-1104.48%--
Upgrade
Return on Assets (ROA)
-98.25%-93.24%-215.14%-291.15%-248.47%-451.53%
Upgrade
Return on Capital (ROIC)
-162.86%-172.06%-314.28%-330.28%-519.93%-
Upgrade
Earnings Yield
-14.34%-86.79%-79.54%-125.73%-0.54%-2.71%
Upgrade
FCF Yield
-11.19%-58.80%-27.08%-12.97%-0.18%-0.93%
Upgrade
Buyback Yield / Dilution
-61.95%-49.84%-79.70%-30.98%-79.11%-18.53%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q